Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 4 Grant or award CFO & Chief Business Officer acquired 99,133 shares (grant or award)
  2. 4 Grant or award Chief Legal Officer & Corp Sec acquired 99,133 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 99,133 shares (grant or award)
  4. 4 Grant or award Chief Operating Officer acquired 84,600 shares (grant or award)
  5. 4 Grant or award Chief Regulatory Officer acquired 84,600 shares (grant or award)
  6. 4 Grant or award President and CDO acquired 166,867 shares (grant or award)
  7. 4 Open-market sale CFO & Chief Business Officer sold 6,888 shares at $1.82 ($12,513)
  8. 4 Open-market sale Chief Operating Officer sold 3,530 shares at $1.86 ($6,562)
  9. 4 Open-market sale Chief Legal Officer & Corp Sec sold 50,659 shares at an average $1.80 ($91,073)
  10. 4 Open-market sale Chief Executive Officer sold 26,472 shares at an average $1.77 ($46,954)
  11. 4 Open-market sale President and CDO sold 8,167 shares at an average $1.85 ($15,148)
  12. 4 Open-market sale Chief Regulatory Officer sold 1,097 shares at $1.98 ($2,176)
  13. 4 Open-market sale CFO & Chief Business Officer sold 14,905 shares at an average $1.97 ($29,436)
  14. 4 Open-market sale Chief Medical Officer sold 10,834 shares at an average $1.96 ($21,277)
  15. 4 Open-market sale Chief Executive Officer sold 47,506 shares at an average $1.98 ($94,176)
  16. 4 Open-market sale Chief Legal Officer & Corp Sec sold 26,668 shares at an average $1.98 ($52,690)
  17. 4 Open-market sale Chief Operating Officer sold 9,318 shares at an average $1.97 ($18,325)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Director acquired 12,800 shares (grant or award)

Page 2 of 7 · 140 filings